CATH Search:   
       by CATH code, keyword
QuickSearch:   
by PDB,NDB,UniProt,PROSITE Code or Search Term(s)  
(use 'Shift Left-Click' to collapse/expand all levels downwards; use 'Control Left-Click' to collapse/expand all levels upwards)
 
(-)
Class: Alpha Beta (26913)
(-)
Architecture: 2-Layer Sandwich (8480)
(-)
Topology: Alpha-Beta Plaits (1688)
(-)
Homologous Superfamily: [code=3.30.70.270, no name defined] (278)
(-)
[unclassified] (58)
1D0EA:25-50,A:125-158,A:188-273; B:25-50,B:125-158,B:188-273CRYSTAL STRUCTURES OF THE N-TERMINAL FRAGMENT FROM MOLONEY MURINE LEUKEMIA VIRUS REVERSE TRANSCRIPTASE COMPLEXED WITH NUCLEIC ACID: FUNCTIONAL IMPLICATIONS FOR TEMPLATE-PRIMER BINDING TO THE FINGERS DOMAIN
1D1UA:25-50,A:125-158,A:188-273USE OF AN N-TERMINAL FRAGMENT FROM MOLONEY MURINE LEUKEMIA VIRUS REVERSE TRANSCRIPTASE TO FACILITATE CRYSTALLIZATION AND ANALYSIS OF A PSEUDO-16-MER DNA MOLECULE CONTAINING G-A MISPAIRS
1HYSB:91-115,B:157-235; A:91-115,A:157-225; A:226-319; B:236-312; A:320-426; B:313-417CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH A POLYPURINE TRACT RNA:DNA
1I6JA:25-50,A:125-158,A:188-273CRYSTAL STRUCTURE OF A PSEUDO-16-MER DNA WITH STACKED GUANINES AND TWO G-A MISPAIRS COMPLEXED WITH THE N-TERMINAL FRAGMENT OF MOLONEY MURINE LEUKEMIA VIRUS REVERSE TRANSCRIPTASE
1J5OB:99-123,B:165-233; A:91-115,A:157-225; A:226-319; B:234-319; A:320-426; B:320-426CRYSTAL STRUCTURE OF MET184ILE MUTANT OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH DOUBLE STRANDED DNA TEMPLATE-PRIMER
1JX4A:2-10,A:78-166CRYSTAL STRUCTURE OF A Y-FAMILY DNA POLYMERASE IN A TERNARY COMPLEX WITH DNA SUBSTRATES AND AN INCOMING NUCLEOTIDE
1JXLA:2-10,A:78-166CRYSTAL STRUCTURE OF A Y-FAMILY DNA POLYMERASE IN A TERNARY COMPLEX WITH DNA SUBSTRATES AND AN INCOMING NUCLEOTIDE
1N48A:2-10,A:78-166Y-FAMILY DNA POLYMERASE DPO4 IN COMPLEX WITH DNA CONTAINING ABASIC LESION
1N4LA:25-50,A:125-158,A:188-273A DNA ANALOGUE OF THE POLYPURINE TRACT OF HIV-1
1N56A:2-10,A:78-166; B:2-10,B:78-166Y-FAMILY DNA POLYMERASE DPO4 IN COMPLEX WITH DNA CONTAINING ABASIC LESION
1N5YB:99-123,B:165-233; A:91-115,A:157-225; B:234-319; A:226-319; A:320-426; B:320-426HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO POST-TRANSLOCATION AZTMP-TERMINATED DNA (COMPLEX P)
1N6QB:99-123,B:165-233; A:91-115,A:157-225; B:234-319; A:226-319; A:320-426; B:320-426HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO PRE-TRANSLOCATION AZTMP-TERMINATED DNA (COMPLEX N)
1QAIA:25-50,A:125-158,A:188-273; B:25-50,B:125-158,B:188-273CRYSTAL STRUCTURES OF THE N-TERMINAL FRAGMENT FROM MOLONEY MURINE LEUKEMIA VIRUS REVERSE TRANSCRIPTASE COMPLEXED WITH NUCLEIC ACID: FUNCTIONAL IMPLICATIONS FOR TEMPLATE-PRIMER BINDING TO THE FINGERS DOMAIN
1QAJA:25-50,A:125-158,A:188-273; B:25-50,B:125-158,B:188-273CRYSTAL STRUCTURES OF THE N-TERMINAL FRAGMENT FROM MOLONEY MURINE LEUKEMIA VIRUS REVERSE TRANSCRIPTASE COMPLEXED WITH NUCLEIC ACID: FUNCTIONAL IMPLICATIONS FOR TEMPLATE-PRIMER BINDING TO THE FINGERS DOMAIN
1R0AB:99-123,B:165-233; A:91-115,A:157-225; B:234-319; A:226-319; A:320-426; B:320-426CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE COVALENTLY TETHERED TO DNA TEMPLATE-PRIMER SOLVED TO 2.8 ANGSTROMS
1RTDB:94-115,B:157-237; D:94-115,D:157-237; A:91-115,A:157-225; C:91-115,C:157-225; B:238-319; D:238-319; A:226-319; C:226-319; A:320-426; C:320-426; B:320-429; D:320-429STRUCTURE OF A CATALYTIC COMPLEX OF HIV-1 REVERSE TRANSCRIPTASE: IMPLICATIONS FOR NUCLEOSIDE ANALOG DRUG RESISTANCE
1RYRA:2-10,A:78-166REPLICATION OF A CIS-SYN THYMINE DIMER AT ATOMIC RESOLUTION
1RYSA:2-10,A:78-166; B:2-10,B:78-166REPLICATION OF A CIS-SYN THYMINE DIMER AT ATOMIC RESOLUTION
1S0MA:2-10,A:78-166; B:2-10,B:78-166CRYSTAL STRUCTURE OF A BENZO[A]PYRENE DIOL EPOXIDE ADDUCT IN A TERNARY COMPLEX WITH A DNA POLYMERASE
1S0NA:2-10,A:78-166SNAPSHOTS OF REPLICATION THROUGH AN ABASIC LESION: STRUCTURAL BASIS FOR BASE SUBSTITUTION AND FRAMESHIFT
1S0OA:2-10,A:78-166; B:2-10,B:78-166SNAPSHOTS OF REPLICATION THROUGH AN ABASIC LESION: STRUCTURAL BASIS FOR BASE SUBSTITUTION AND FRAMESHIFT
1S10A:2-10,A:78-166SNAPSHOTS OF REPLICATION THROUGH AN ABASIC LESION: STRUCTURAL BASIS FOR BASE SUBSTITUTION AND FRAMESHIFT
1S97A:2-10,A:78-166; B:2-10,B:78-166; C:2-10,C:78-166; D:2-10,D:78-166DPO4 WITH GT MISMATCH
1S9FA:2-10,A:78-166; B:2-10,B:78-166; C:2-10,C:78-166; D:2-10,D:78-166DPO WITH AT MATCHED
1T03A:91-115,A:157-225; B:238-319; A:226-319; A:320-426; B:320-429; B:94-115,B:157-237HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO TENOFOVIR TERMINATED TEMPLATE-PRIMER (COMPLEX P)
1T05B:94-115,B:157-237; A:91-115,A:157-225; B:238-319; A:226-319; A:320-426; B:320-429HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO TEMPLATE-PRIMER WITH TENOFOVIR-DIPHOSPHATE BOUND AS THE INCOMING NUCLEOTIDE SUBSTRATE
1T3NA:27-36,A:99-221; B:447-456,B:519-641STRUCTURE OF THE CATALYTIC CORE OF DNA POLYMERASE IOTA IN COMPLEX WITH DNA AND DTTP
1WNEA:208-248,A:303-403FOOT AND MOUTH DISEASE VIRUS RNA-DEPENDENT RNA POLYMERASE IN COMPLEX WITH A TEMPLATE-PRIMER RNA
1ZETA:27-36,A:99-221X-RAY DATA DO NOT SUPPORT HOOGSTEEN BASE-PAIRING DURING REPLICATION BY HUMAN POLYMERASE IOTA
1ZTTA:25-50,A:125-158,A:188-273NETROPSIN BOUND TO D(CTTAATTCGAATTAAG) IN COMPLEX WITH MMLV RT CATALYTIC FRAGMENT
1ZTWA:25-50,A:125-158,A:188-273D(CTTAATTCGAATTAAG) COMPLEXED WITH MOLONEY MURINE LEUKEMIA VIRUS REVERSE TRANSCRIPTASE CATALYTIC FRAGMENT
2AGOA:2-10,A:78-166FIDELITY OF DPO4: EFFECT OF METAL IONS, NUCLEOTIDE SELECTION AND PYROPHOSPHOROLYSIS
2AGPA:2-10,A:78-166; B:2-10,B:78-166FIDELITY OF DPO4: EFFECT OF METAL IONS, NUCLEOTIDE SELECTION AND PYROPHOSPHOROLYSIS
2AGQA:2-10,A:78-166FIDELITY OF DPO4: EFFECT OF METAL IONS, NUCLEOTIDE SELECTION AND PYROPHOSPHOROLYSIS
2ALZA:25-36,A:99-221TERNARY COMPLEX OF HPOLI WITH DNA AND DCTP
2ASDA:2-10,A:78-166; B:1002-1010,B:1078-1166OXOG-MODIFIED INSERTION TERNARY COMPLEX
2ASJA:2-10,A:78-166; B:1002-1010,B:1078-1166OXOG-MODIFIED PREINSERTION BINARY COMPLEX
2ASLA:2-10,A:78-166; B:1002-1010,B:1078-1166OXOG-MODIFIED POSTINSERTION BINARY COMPLEX
2ATLA:2-10,A:78-166; B:1002-1010,B:1078-1166UNMODIFIED INSERTION TERNARY COMPLEX
2AU0A:2-10,A:78-166; B:1002-1010,B:1078-1166UNMODIFIED PREINSERTION BINARY COMPLEX
2DPIA:26-36,A:99-221TERNARY COMPLEX OF HPOLI WITH DNA AND DCTP
2DPJA:25-36,A:99-221STRUCTURE OF HPOLI WITH DNA AND DTTP
2E9RX:208-248,X:303-403FOOT-AND-MOUTH DISEASE VIRUS RNA-DEPENDENT RNA POLYMERASE IN COMPLEX WITH A TEMPLATE-PRIMER RNA AND WITH RIBAVIRIN
2E9TA:208-248,A:303-403; D:208-248,D:303-403FOOT-AND-MOUTH DISEASE VIRUS RNA-POLYMERASE RNA DEPENDENT IN COMPLEX WITH A TEMPLATE-PRIMER RNA AND 5F-UTP
2E9ZA:208-248,A:303-403FOOT-AND-MOUTH DISEASE VIRUS RNA-POLYMERASE IN COMPLEX WITH A TEMPLATE- PRIMER RNA, ATP AND UTP
2EC0A:208-248,A:303-403; D:208-248,D:303-403RNA-DEPENDENT RNA POLYMERASE OF FOOT-AND-MOUTH DISEASE VIRUS IN COMPLEX WITH A TEMPLATE-PRIMER RNA AND ATP
2FJVA:25-50,A:125-158,A:188-273RT29 BOUND TO D(CTTAATTCGAATTAAG) IN COMPLEX WITH MMLV RT CATALYTIC FRAGMENT
2FJWA:25-50,A:125-158,A:188-273D(CTTGAATGCATTCAAG) IN COMPLEX WITH MMLV RT CATALYTIC FRAGMENT
2FJXA:25-50,A:125-158,A:188-273RT29 BOUND TO D(CTTGAATGCATTCAAG) IN COMPLEX WITH MMLV RT CATALYTIC FRAGMENT
2FLLA:25-36,A:99-221TERNARY COMPLEX OF HUMAN DNA POLYMERASE IOTA WITH DNA AND DTTP
2FLNA:26-36,A:99-221BINARY COMPLEX OF CATALYTIC CORE OF HUMAN DNA POLYMERASE IOTA WITH DNA (TEMPLATE A)
2FLPA:26-36,A:99-221BINARY COMPLEX OF THE CATALYTIC CORE OF HUMAN DNA POLYMERASE IOTA WITH DNA (TEMPLATE G)
2FVPA:25-50,A:125-158,A:188-273A STRUCTURAL STUDY OF THE CA DINUCLEOTIDE STEP IN THE INTEGRASE PROCESSING SITE OF MOLONEY MURINE LEUKEMIA VIRUS
2FVQA:25-50,A:125-158,A:188-273A STRUCTURAL STUDY OF THE CA DINUCLEOTIDE STEP IN THE INTEGRASE PROCESSING SITE OF MOLONEY MURINE LEUKEMIA VIRUS
2FVRA:25-50,A:125-158,A:188-273A STRUCTURAL STUDY OF THE CA DINUCLEOTIDE STEP IN THE INTEGRASE PROCESSING SITE OF MOLONEY MURINE LEUKEMIA VIRUS
2FVSA:25-50,A:125-158,A:188-273A STRUCTURAL STUDY OF THE CA DINUCLEOTIDE STEP IN THE INTEGRASE PROCESSING SITE OF MOLONEY MURINE LEUKEMIA VIRUS
2HMIA:91-115,A:157-225; B:99-115,B:157-225; A:226-319; B:226-319; A:320-426; B:320-426HIV-1 REVERSE TRANSCRIPTASE/FRAGMENT OF FAB 28/DNA COMPLEX
2IMWP:2-10,P:78-166MECHANISM OF TEMPLATE-INDEPENDENT NUCLEOTIDE INCORPORATION CATALYZED BY A TEMPLATE-DEPENDENT DNA POLYMERASE
(-)
Caulobacter vibrioides. Organism_taxid: 190650. Strain: cb15. (1)
1W25B:283-455; A:280-455RESPONSE REGULATOR PLED IN COMPLEX WITH C-DIGMP
(-)
Foot-and-mouth disease virus - type c. Organism_taxid: 12116. Strain:c-s8c1. (1)
2F8EX:208-248,X:303-403FOOT AND MOUTH DISEASE VIRUS RNA-DEPENDENT RNA POLYMERASE IN COMPLEX WITH URIDYLYLATED VPG PROTEIN
(-)
Foot-and-mouth disease virus c-s8c1. Organism_taxid: 244367. Strain: c-s8c1. (2)
1U09A:208-248,A:303-403FOOTAND MOUTH DISEASE VIRUS RNA-DEPENDENT RNA POLYMERASE
2D7SA:208-248,A:303-403FOOT AND MOUTH DISEASE VIRUS RNA-DEPENDENT RNA POLYMERASE IN COMPLEX WITH VPG PROTEIN
(-)
Hcv (Hepatitis c virus (isolate bk)) (3)
1GX5A:188-228,A:286-366HEPATITIS C VIRUS RNA POLYMERASE IN COMPLEX WITH GTP AND MANGANESE
1GX6A:188-228,A:286-366HEPATITIS C VIRUS RNA POLYMERASE IN COMPLEX WITH UTP AND MANGANESE
3D28B:192-228,B:286-368CRYSTAL STRUCTURE OF HCV NS5B POLYMERASE WITH A NOVEL BENZISOTHIAZOLE INHIBITOR
(-)
Hcv (Hepatitis c virus) (1)
3FQKA:188-228,A:286-366HEPATITIS C VIRUS POLYMERASE NS5B (BK 1-570) WITH HCV-796 INHIBITOR
(-)
Hepatitis c virus subtype 1b. Organism_taxid: 31647. Strain: genotype1b. Strain bk. (6)
3CIZA:188-228,A:286-366; B:188-228,B:286-366CRYSTAL STRUCTURE OF HEPATITIS C VIRUS RNA-DEPENDENT RNA POLYMERASE NS5B IN COMPLEX WITH SMALL MOLECULE FRAGMENTS
3CJ0A:188-228,A:286-366; B:188-228,B:286-366CRYSTAL STRUCTURE OF HEPATITIS C VIRUS RNA-DEPENDENT RNA POLYMERASE NS5B IN COMPLEX WITH SMALL MOLECULE FRAGMENTS
3CJ2A:188-228,A:286-366; B:188-228,B:286-366CRYSTAL STRUCTURE OF HEPATITIS C VIRUS RNA-DEPENDENT RNA POLYMERASE NS5B IN COMPLEX WITH OPTIMIZED SMALL MOLECULE FRAGMENTS
3CJ3A:188-228,A:286-366; B:188-228,B:286-366CRYSTAL STRUCTURE OF HEPATITIS C VIRUS RNA-DEPENDENT RNA POLYMERASE NS5B IN COMPLEX WITH OPTIMIZED SMALL MOLECULE FRAGMENTS
3CJ4A:188-228,A:286-366; B:188-228,B:286-366CRYSTAL STRUCTURE OF HEPATITIS C VIRUS RNA-DEPENDENT RNA POLYMERASE NS5B IN COMPLEX WITH OPTIMIZED SMALL MOLECULE FRAGMENTS
3CJ5A:188-228,A:286-366; B:188-228,B:286-366CRYSTAL STRUCTURE OF HEPATITIS C VIRUS RNA-DEPENDENT RNA POLYMERASE NS5B IN COMPLEX WITH OPTIMIZED SMALL MOLECULE FRAGMENTS
(-)
Hepatitis c virus. Organism_taxid: 11103. (2)
1C2PA:188-228,A:286-366; B:188-228,B:286-366HEPATITIS C VIRUS NS5B RNA-DEPENDENT RNA POLYMERASE
1CSJA:188-228,A:286-366; B:188-228,B:286-366CRYSTAL STRUCTURE OF THE RNA-DEPENDENT RNA POLYMERASE OF HEPATITIS C VIRUS
(-)
Hepatitis c virus. Organism_taxid: 11103. Strain: 1b (bk). (1)
1QUVA:192-228,A:286-368CRYSTAL STRUCTURE OF THE RNA DIRECTED RNA POLYMERASE OF HEPATITIS C VIRUS
(-)
Hiv-1 (Human immunodeficiency virus 1) (3)
2VG5B:1091-1115,B:1157-1243; A:320-426; B:1244-1318; A:91-115,A:157-225; A:226-319; B:1319-1428CRYSTAL STRUCTURES OF HIV-1 REVERSE TRANSCRIPTASE COMPLEXES WITH THIOCARBAMATE NON-NUCLEOSIDE INHIBITORS
2VG6B:1091-1115,B:1157-1243; B:1319-1428; A:320-426; B:1244-1318; A:91-115,A:157-225; A:226-319CRYSTAL STRUCTURES OF HIV-1 REVERSE TRANSCRIPTASE COMPLEXES WITH THIOCARBAMATE NON-NUCLEOSIDE INHIBITORS
2VG7B:1091-1115,B:1157-1243; B:1319-1428; A:320-426; B:1244-1318; A:91-115,A:157-225; A:226-319CRYSTAL STRUCTURES OF HIV-1 REVERSE TRANSCRIPTASE COMPLEXES WITH THIOCARBAMATE NON-NUCLEOSIDE INHIBITORS
(-)
Hiv-1 (Human immunodeficiency virus type 1 (hxb2 isolate)) (1)
3DI6A:91-115,A:157-225; B:91-115,B:157-236; A:226-319; A:320-426; B:237-341; B:342-426HIV-1 RT WITH PYRIDAZINONE NON-NUCLEOSIDE INHIBITOR
(-)
Hiv-1 (Human immunodeficiency virus type 1 bh10) (5)
3DLKB:93-115,B:157-243; A:320-426; B:319-428; B:244-318; A:91-115,A:157-225; A:226-319CRYSTAL STRUCTURE OF AN ENGINEERED FORM OF THE HIV-1 REVERSE TRANSCRIPTASE, RT69A
3IG1B:99-123,B:165-233; A:226-319; B:234-319; A:320-426; B:320-427; A:91-115,A:157-225HIV-1 REVERSE TRANSCRIPTASE WITH THE INHIBITOR BETA-THUJAPLICINOL BOUND AT THE RNASE H ACTIVE SITE
3IRXB:99-123,B:165-233; A:226-319; B:234-319; A:320-426; B:320-427; A:91-115,A:157-225CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH THE NON-NUCLEOSIDE RT INHIBITOR (E)-S-METHYL 5-(1-(3,7-DIMETHYL-2-OXO-2,3-DIHYDROBENZO[D]OXAZOL-5-YL)-5-(5-METHYL-1,3,4-OXADIAZOL-2-YL)PENT-1-ENYL)-2-METHOXY-3-METHYLBENZOTHIOATE.
3IS9B:99-123,B:165-233; A:226-319; B:234-319; A:320-426; B:320-427; A:91-115,A:157-225CRYSTAL STRUCTURE OF THE HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH THE ALKENYLDIARYLMETHANE (ADAM) NON-NUCLEOSIDE RT INHIBITOR DIMETHYL 3,3'-(6-METHOXY-6-OXOHEX-1-ENE-1,1-DIYL)BIS(5-CYANO-6-METHOXYBENZOATE).
3JSMA:91-115,A:157-225; B:238-319; A:226-319; A:320-426; B:320-428; B:94-115,B:157-237K65R MUTANT HIV-1 REVERSE TRANSCRIPTASE CROSS-LINKED TO DS-DNA AND COMPLEXED WITH TENOFOVIR-DIPHOSPHATE AS THE INCOMING NUCLEOTIDE SUBSTRATE
(-)
Hiv-1 (Human immunodeficiency virus type 1) (17)
3DM2B:99-115,B:157-238; A:91-115,A:157-225; B:239-319; A:226-319; A:320-426; B:320-426CRYSTAL STRUCTURE OF HIV-1 K103N MUTANT REVERSE TRANSCRIPTASE IN COMPLEX WITH GW564511.
3DMJB:99-115,B:157-233; A:91-115,A:157-225; B:234-319; A:226-319; A:320-426; B:320-437CRYSTAL STRUCTURE OF HIV-1 V106A AND Y181C MUTANT REVERSE TRANSCRIPTASE IN COMPLEX WITH GW564511.
3DOKB:95-115,B:157-233; A:91-115,A:157-225; B:234-319; A:226-319; A:320-426; B:320-426CRYSTAL STRUCTURE OF K103N MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GW678248.
3DOLB:99-115,B:157-233; B:234-319; A:226-319; A:320-426; B:320-426; A:91-115,A:157-225CRYSTAL STRUCTURE OF L100I MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GW695634.
3DRPA:91-115,A:157-225; A:226-319; A:320-426; B:237-341; B:91-115,B:157-236; B:342-426HIV REVERSE TRANSCRIPTASE IN COMPLEX WITH INHIBITOR R8E
3DRRA:91-115,A:157-225; B:91-115,B:157-236; A:226-319; A:320-426; B:237-341; B:342-426HIV REVERSE TRANSCRIPTASE Y181C MUTANT IN COMPLEX WITH INHIBITOR R8E
3DRSA:91-115,A:157-225; B:91-115,B:157-236; A:226-319; A:320-426; B:237-341; B:342-426HIV REVERSE TRANSCRIPTASE K103N MUTANT IN COMPLEX WITH INHIBITOR R8D
3E01A:91-115,A:157-225; B:91-115,B:157-236; A:226-319; A:320-426; B:237-341; B:342-426HIV-RT WITH NON-NUCLEOSIDE INHIBITOR ANNULATED PYRAZOLE 2
3JYTA:91-115,A:157-225; B:238-319; A:226-319; A:320-426; B:320-428; B:94-115,B:157-237K65R MUTANT HIV-1 REVERSE TRANSCRIPTASE CROSS-LINKED TO DS-DNA AND COMPLEXED WITH DATP AS THE INCOMING NUCLEOTIDE SUBSTRATE
3KJVB:95-115,B:157-236; A:91-115,A:157-225; A:226-319; A:320-426; B:237-341; B:342-426HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH DNA
3KK1A:91-115,A:157-225; A:226-319; A:320-426; B:237-341; B:342-426; B:92-115,B:157-236HIV-1 REVERSE TRANSCRIPTASE-DNA COMPLEX WITH NUCEOTIDE INHIBITOR GS-9148-DIPHOSPHATE BOUND IN NUCLEOTIDE SITE
3KK2A:91-115,A:157-225; B:92-115,B:157-236; A:226-319; A:320-426; B:237-341; B:342-426HIV-1 REVERSE TRANSCRIPTASE-DNA COMPLEX WITH DATP BOUND IN THE NUCLEOTIDE BINDING SITE
3KK3A:91-115,A:157-225; B:92-115,B:157-236; A:226-319; A:320-426; B:237-341; B:342-426HIV-1 REVERSE TRANSCRIPTASE-DNA COMPLEX WITH GS-9148 TERMINATED PRIMER
3LAKA:91-115,A:157-225; B:99-123,B:165-233; A:226-319; B:234-319; B:320-426; A:320-426CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH N1-HETEROCYCLE PYRIMIDINEDIONE NON-NUCLEOSIDE INHIBITOR
3LALA:91-115,A:157-225; B:99-123,B:165-233; A:226-319; B:234-319; B:320-426; A:320-426CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH N1-ETHYL PYRIMIDINEDIONE NON-NUCLEOSIDE INHIBITOR
3LAMA:91-115,A:157-225; B:99-123,B:165-233; A:226-319; B:234-319; B:320-426; A:320-426CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH N1-PROPYL PYRIMIDINEDIONE NON-NUCLEOSIDE INHIBITOR
3LANA:91-115,A:157-225; B:99-123,B:165-233; A:226-319; B:234-319; B:320-426; A:320-426CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH N1-BUTYL PYRIMIDINEDIONE NON-NUCLEOSIDE INHIBITOR
(-)
Hiv-1 (Human immunodeficiency virus) (2)
3ISND:94-115,D:157-239; D:320-424; C:320-426; C:91-115,C:157-225; C:226-319; D:240-319CRYSTAL STRUCTURE OF HIV-1 RT BOUND TO A 6-VINYLPYRIMIDINE INHIBITOR
3ITHD:94-115,D:157-239; D:240-319; B:320-424; D:320-424; A:320-426; C:320-426; B:92-115,B:157-239; A:91-115,A:157-225; C:91-115,C:157-225; A:226-319; C:226-319; B:240-319CRYSTAL STRUCTURE OF THE HIV-1 REVERSE TRANSCRIPTASE BOUND TO A 6-VINYLPYRIMIDINE INHIBITOR
(-)
Hiv-1 m:b_hxb2r. Hiv-1. Organism_taxid: 11706. (1)
3FFIA:91-115,A:157-225; B:91-115,B:157-236; A:226-319; A:320-426; B:237-341; B:342-426HIV-1 RT WITH PYRIDONE NON-NUCLEOSIDE INHIBITOR
(-)
Hiv-1 m:b_hxb2r. Hiv-1. Organism_taxid: 11706. Strain: hxb2 isolate. (5)
3DLEB:99-115,B:157-233; B:234-319; A:226-319; A:320-426; B:320-426; A:91-115,A:157-225CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GF128590.
3DLGB:99-115,B:157-233; A:226-319; B:234-319; A:320-426; B:320-426; A:91-115,A:157-225CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GW564511.
3DYAA:91-115,A:157-225; A:226-319; A:320-426; B:237-341; B:342-426; B:91-115,B:157-236HIV-1 RT WITH NON-NUCLEOSIDE INHIBITOR ANNULATED PYRAZOLE 1
3I0RA:91-115,A:157-225; A:226-319; A:320-426; B:237-341; B:342-426; B:91-115,B:157-236CRYSTAL STRUCTURE OF HIV REVERSE TRANSCRIPTASE IN COMPLEX WITH INHIBITOR 3
3I0SA:91-115,A:157-225; A:226-319; A:320-426; B:237-341; B:342-426; B:91-115,B:157-236CRYSTAL STRUCTURE OF HIV REVERSE TRANSCRIPTASE IN COMPLEX WITH INHIBITOR 7
(-)
Hiv-1 m:b_hxb2r. Organism_taxid: 11706. Strain: hxb2 isolate. (18)
1JKHB:97-115,B:157-233; A:91-115,A:157-225; B:234-319; A:226-319; A:320-426; B:320-426CRYSTAL STRUCTURE OF Y181C MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH DMP-266(EFAVIRENZ)
1JLAB:99-115,B:157-233; A:91-115,A:157-225; B:234-319; A:226-319; A:320-426; B:320-438CRYSTAL STRUCTURE OF Y181C MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH TNK-651
1JLBA:91-115,A:157-225; B:99-115,B:157-188; A:226-319; A:320-426; B:320-426; B:189-319CRYSTAL STRUCTURE OF Y181C MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH NEVIRAPINE
1JLCB:97-115,B:157-233; B:234-366; B:367-430; A:91-115,A:157-225; A:226-319; A:320-426CRYSTAL STRUCTURE OF Y181C MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH PETT-2
1JLEA:91-115,A:157-225; B:99-115,B:157-188; A:226-319; A:320-426; B:320-426; B:189-319CRYSTAL STRUCTURE OF Y188C MUTANT HIV-1 REVERSE TRANSCRIPTASE
1JLFB:99-115,B:157-233; A:91-115,A:157-225; B:234-319; A:226-319; A:320-426; B:320-426CRYSTAL STRUCTURE OF Y188C MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH NEVIRAPINE
1JLGB:99-115,B:157-233; A:91-115,A:157-225; B:234-319; A:226-319; A:320-426; B:320-426CRYSTAL STRUCTURE OF Y188C MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH UC-781
1RT4A:91-115,A:157-225; B:99-115,B:157-188; A:226-319; A:320-426; B:320-426; B:189-319HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH UC781
1RT5A:91-115,A:157-225; B:99-123,B:165-235; B:236-319; A:226-319; A:320-426; B:320-426HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH UC10
1RT6B:95-115,B:157-235; A:91-115,A:157-225; A:226-319; A:320-426; B:236-341; B:342-417HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH UC38
1RT7A:91-115,A:157-225; B:99-123,B:165-237; B:238-319; A:226-319; A:320-426; B:320-426HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH UC84
2OPPB:88-115,B:157-243; A:92-115,A:157-225; A:226-319; A:320-426; B:319-431; B:244-318CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GW420867X.
2OPQB:96-115,B:157-243; B:244-318; A:226-319; B:319-428; A:320-426; A:91-115,A:157-225CRYSTAL STRUCTURE OF L100I MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GW420867X.
2OPRB:94-115,B:157-243; B:244-318; A:92-115,A:157-225; A:226-319; A:320-426; B:319-431CRYSTAL STRUCTURE OF K101E MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GW420867X.
2OPSA:92-115,A:157-225; B:99-115,B:157-188; A:226-319; A:320-426; B:320-426; B:189-319CRYSTAL STRUCTURE OF Y188C MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GW420867X.
2RF2A:91-115,A:157-225; B:91-115,B:157-236; A:226-319; A:320-426; B:237-341; B:342-426HIV REVERSE TRANSCRIPTASE IN COMPLEX WITH INHIBITOR 7E (NNRTI)
3C6TA:91-115,A:157-225; B:91-115,B:157-236; A:226-319; A:320-426; B:237-341; B:342-426CRYSTAL STRUCTURE OF HIV REVERSE TRANSCRIPTASE IN COMPLEX WITH INHIBITOR 14
3C6UA:91-115,A:157-225; B:91-115,B:157-236; A:226-319; A:320-426; B:237-341; B:342-426CRYSTAL STRUCTURE OF HIV REVERSE TRANSCRIPTASE IN COMPLEX WITH INHIBITOR 22
(-)
Hiv-1 m:b_hxb2r. Organism_taxid: 11706. Strain: hxb2 isolate. (1)
1JLQB:99-115,B:157-233; A:91-115,A:157-225; B:234-319; A:226-319; A:320-426; B:320-426CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH 739W94
(-)
Human (Homo sapiens) (12)
1T94B:102-109,B:169-335; A:102-109,A:169-224,A:283-338CRYSTAL STRUCTURE OF THE CATALYTIC CORE OF HUMAN DNA POLYMERASE KAPPA
3EPGA:25-36,A:99-221STRUCTURE OF HUMAN DNA POLYMERASE IOTA COMPLEXED WITH N2-ETHYLGUANINE
3EPIA:25-36,A:99-221STRUCTURE OF HUMAN DNA POLYMERASE IOTA COMPLEXED WITH N2-ETHYLGUANINE AND INCOMING TTP
3G6VA:25-36,A:99-221DNA SYNTHESIS ACROSS AN ABASIC LESION BY HUMAN DNA POLYMERASE-IOTA
3G6XA:25-36,A:99-221TERNARY COMPLEX OF DNA POLYMERASE IOTA:DNA:DGTP WITH AN ABASIC SITE AT THE TEMPLATING POSITION
3G6YA:25-36,A:99-221TERNARY COMPLEX OF DNA POLYMERASE IOTA:DNA:DTTP WITH AN ABASIC SITE AT THE TEMPLATING POSITION
3GV5B:28-36,B:99-221; D:26-36,D:99-221HUMAN DNA POLYMERASE IOTA IN COMPLEX WITH T TEMPLATE DNA AND INCOMING DDADP
3GV7B:26-36,B:99-221HUMAN DNA POLYMERASE IOTA IN COMPLEX WITH T TEMPLATE DNA AND INCOMING DTTP
3GV8B:26-36,B:99-221HUMAN DNA POLYMERASE IOTA IN COMPLEX WITH T TEMPLATE DNA AND INCOMING DGTP
3H40A:26-36,A:99-221BINARY COMPLEX OF HUMAN DNA POLYMERASE IOTA WITH TEMPLATE U/T
3H4BA:25-36,A:99-221TERNARY COMPLEX OF HUMAN DNA POLYMERASE IOTA WITH TEMPLATE U/T AND INCOMING DATP
3H4DA:25-36,A:99-221TERNARY COMPLEX OF HUMAN DNA POLYMERASE IOTA WITH TEMPLATE U/T AND INCOMING DGTP
(-)
Human immunodeficiency virus 1. Organism_taxid: 11676. (2)
1HNIB:95-115,B:157-235; A:91-115,A:157-225; B:320-426; A:226-319; B:236-319; A:320-426STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN A COMPLEX WITH THE NONNUCLEOSIDE INHIBITOR ALPHA-APA R 95845 AT 2.8 ANGSTROMS RESOLUTION
3HVTA:91-115,A:157-225; B:250-319; B:91-115,B:157-225; A:226-319; B:320-428; A:320-428STRUCTURAL BASIS OF ASYMMETRY IN THE HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 REVERSE TRANSCRIPTASE HETERODIMER
(-)
Human immunodeficiency virus 1. Organism_taxid: 11676. (27)
1EETB:1094-1115,B:1157-1239; A:320-426; A:91-115,A:157-225; A:226-319; B:1240-1319; B:1320-1424HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH THE INHIBITOR MSC204
1HMVA:91-115,A:157-225; B:320-425; D:320-425; F:320-425; H:320-425; A:320-426; C:320-426; E:320-426; G:320-426; B:189-319; D:189-319; F:189-319; H:189-319; B:99-115,B:157-188; D:99-115,D:157-188; F:99-115,F:157-188; H:99-115,H:157-188; C:91-115,C:157-225; E:91-115,E:157-225; G:91-115,G:157-225; A:226-319; C:226-319; E:226-319; G:226-319THE STRUCTURE OF UNLIGANDED REVERSE TRANSCRIPTASE FROM THE HUMAN IMMUNODEFICIENCY VIRUS TYPE 1
1IKVB:1099-1115,B:1157-1239; B:1320-1424; A:320-426; A:91-115,A:157-225; A:226-319; B:1240-1319K103N MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH EFIVARENZ
1IKWB:1095-1115,B:1157-1239; B:1320-1425; A:320-426; A:91-115,A:157-225; A:226-319; B:1240-1319WILD TYPE HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH EFAVIRENZ
1IKXB:1095-1115,B:1157-1239; A:320-426; B:1317-1417; A:91-115,A:157-225; A:226-319; B:1240-1316K103N MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH THE INHIBITOR PNU142721
1IKYB:1094-1115,B:1157-1239; A:320-426; B:1322-1425; B:1240-1321; A:91-115,A:157-225; A:226-319HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH THE INHIBITOR MSC194
1LW0B:96-115,B:157-233; B:320-425; A:320-426; A:91-115,A:157-225; B:234-319; A:226-319CRYSTAL STRUCTURE OF T215Y MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH NEVIRAPINE
1LW2B:99-123,B:165-238; B:320-425; A:320-426; A:91-115,A:157-225; B:239-319; A:226-319CRYSTAL STRUCTURE OF T215Y MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH 1051U91
1LWCB:234-319; A:320-426; A:91-115,A:157-225; B:95-115,B:157-233; A:226-319; B:320-425CRYSTAL STRUCTURE OF M184V MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH NEVIRAPINE
1LWEB:99-123,B:165-235; A:320-426; B:320-426; A:91-115,A:157-225; B:236-319; A:226-319CRYSTAL STRUCTURE OF M41L/T215Y MUTANT HIV-1 REVERSE TRANSCRIPTASE (RTMN) IN COMPLEX WITH NEVIRAPINE
1LWFA:226-319; A:320-426; B:320-426; A:91-115,A:157-225; B:189-319; B:99-115,B:157-188CRYSTAL STRUCTURE OF A MUTANT HIV-1 REVERSE TRANSCRIPTASE (RTMQ+M184V: M41L/D67N/K70R/M184V/T215Y) IN COMPLEX WITH NEVIRAPINE
1S1TB:95-115,B:157-235; B:236-341; A:91-115,A:157-225; B:342-417; A:226-319; A:320-426CRYSTAL STRUCTURE OF L100I MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH UC-781
1S1UB:96-115,B:157-233; B:320-425; A:320-426; A:91-115,A:157-225; B:234-319; A:226-319CRYSTAL STRUCTURE OF L100I MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH NEVIRAPINE
1S1VA:226-319; A:320-426; B:320-426; A:91-115,A:157-225; B:189-319; B:99-115,B:157-188CRYSTAL STRUCTURE OF L100I MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH TNK-651
1S1WB:95-115,B:157-233; A:320-426; A:91-115,A:157-225; B:234-319; A:226-319; B:320-425CRYSTAL STRUCTURE OF V106A MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH UC-781
1S1XB:233-319; B:320-426; A:320-426; A:91-115,A:157-225; B:99-115,B:157-215; A:226-319CRYSTAL STRUCTURE OF V108I MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH NEVIRAPINE
1S6PB:99-123,B:165-233; A:320-426; B:320-426; A:91-115,A:157-225; A:226-319; B:234-319CRYSTAL STRUCTURE OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH JANSSEN-R100943
1S6QB:99-123,B:165-233; A:320-426; B:320-426; A:91-115,A:157-225; A:226-319; B:234-319CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH JANSSEN-R147681
1S9EA:91-115,A:157-225; A:320-426; B:323-427; B:244-322; B:85-119,B:151-243; A:226-319CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH JANSSEN-R129385
1S9GB:99-123,B:165-233; A:320-426; B:320-426; A:91-115,A:157-225; A:226-319; B:234-319CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH JANSSEN-R120394.
2B6AB:99-123,B:165-233; A:320-426; B:320-426; A:91-115,A:157-225; A:226-319; B:234-319CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH THR-50
2HNDA:91-115,A:157-225; A:320-426; B:88-115,B:157-243; B:244-318; A:226-319; B:319-428CRYSTAL STRUCTURE OF K101E MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH NEVIRAPINE
2HNYB:88-115,B:157-243; A:320-426; A:91-115,A:157-225; B:244-318; A:226-319; B:319-428CRYSTAL STRUCTURE OF E138K MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH NEVIRAPINE
2RKIA:91-115,A:157-225; B:91-115,B:157-236; B:237-341; B:342-426; A:226-319; A:320-426CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH A TRIAZOLE DERIVED NNRTI
2ZD1B:99-123,B:165-233; A:91-115,A:157-225; A:226-319; B:234-319; A:320-426; B:320-427CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH TMC278 (RILPIVIRINE), A NON-NUCLEOSIDE RT INHIBITOR
2ZE2B:99-123,B:165-233; A:320-426; B:320-427; A:91-115,A:157-225; A:226-319; B:234-319CRYSTAL STRUCTURE OF L100I/K103N MUTANT HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH TMC278 (RILPIVIRINE), A NON-NUCLEOSIDE RT INHIBITOR
3BGRB:99-123,B:165-233; A:91-115,A:157-225; A:226-319; B:234-319; A:320-426; B:320-427CRYSTAL STRUCTURE OF K103N/Y181C MUTANT HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH TMC278 (RILPIVIRINE), A NON-NUCLEOSIDE RT INHIBITOR
(-)
Human immunodeficiency virus 1. Organism_taxid: 11676. (9)
1DTQA:91-115,A:157-225; A:226-319; A:320-426; B:237-341; B:342-426; B:91-115,B:157-236CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH PETT-1 (PETT131A94)
1DTTB:94-115,B:157-237; A:226-319; A:320-426; B:322-432; B:238-321; A:91-115,A:157-225CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH PETT-2 (PETT130A94)
1HARA:104-115,A:160-2162.2 ANGSTROMS RESOLUTION STRUCTURE OF THE AMINO-TERMINAL HALF OF HIV-1 REVERSE TRANSCRIPTASE (FINGERS AND PALM SUBDOMAINS)
1HNVB:95-115,B:157-235; A:91-115,A:157-225; A:226-319; B:236-319; A:320-426; B:320-426STRUCTURE OF HIV-1 RT(SLASH)TIBO R 86183 COMPLEX REVEALS SIMILARITY IN THE BINDING OF DIVERSE NONNUCLEOSIDE INHIBITORS
1HPZB:99-115,B:157-238; A:91-115,A:157-225; A:226-319; B:239-319; A:320-426; B:320-426HUMAN IMMUNODEFICIENCY VIRUS TYPE 1
1HQEB:99-115,B:157-238; A:91-115,A:157-225; A:226-319; B:239-319; A:320-426; B:320-426HUMAN IMMUNODEFICIENCY VIRUS TYPE 1
1HQUB:95-115,B:157-234; A:91-115,A:157-225; A:226-319; B:235-319; A:320-426; B:320-426HUMAN IMMUNODEFICIENCY VIRUS TYPE 1
2WOMB:95-115,B:157-233; A:91-115,A:157-225; A:226-319; B:234-319; A:320-426; B:320-426CRYSTAL STRUCTURE OF UK-453061 BOUND TO HIV-1 REVERSE TRANSCRIPTASE (K103N).
2WONA:91-115,A:157-225; A:226-319; A:320-426; B:237-341; B:342-426; B:93-115,B:157-236CRYSTAL STRUCTURE OF UK-453061 BOUND TO HIV-1 REVERSE TRANSCRIPTASE (WILD-TYPE).
(-)
Human immunodeficiency virus 1. Organism_taxid: 11676. Cell_line: 293. (1)
1VRUB:94-115,B:157-238; A:91-115,A:157-225; B:239-319; A:226-319; B:320-426; A:320-426HIGH RESOLUTION STRUCTURES OF HIV-1 RT FROM FOUR RT-INHIBITOR COMPLEXES
(-)
Human immunodeficiency virus 1. Organism_taxid: 11676. Strain: bh10 isolate. (1)
2B5JB:99-123,B:165-233; A:91-115,A:157-225; A:226-319; B:234-319; A:320-426; B:320-426CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH JANSSEN-R165481
(-)
Human immunodeficiency virus 1. Organism_taxid: 11676. Strain: bh10 isolate. (4)
1DLOA:91-115,A:157-225; B:239-316; A:320-426; B:317-426; B:93-115,B:157-238; A:226-319HUMAN IMMUNODEFICIENCY VIRUS TYPE 1
1SUQB:99-123,B:165-233; A:226-319; B:234-319; A:320-426; B:320-426; A:91-115,A:157-225CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH JANSSEN-R185545
1SV5B:99-115,B:157-238; B:239-319; A:320-426; B:320-426; A:91-115,A:157-225; A:226-319CRYSTAL STRUCTURE OF K103N MUTANT HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH JANSSEN-R165335
2BANB:99-123,B:165-233; B:234-319; A:320-426; B:320-426; A:91-115,A:157-225; A:226-319CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH JANSSEN-R157208
(-)
Human immunodeficiency virus 1. Organism_taxid: 11676. Strain: bh10. Cell_line: 293. (2)
1BQMB:99-123,B:165-233; A:91-115,A:157-225; A:226-319; B:234-319; A:320-426; B:320-426HIV-1 RT/HBY 097
1UWBB:95-115,B:157-235; A:320-426; B:320-426; A:91-115,A:157-225; A:226-319; B:236-319TYR 181 CYS HIV-1 RT/8-CL TIBO
(-)
Human immunodeficiency virus 1. Organism_taxid: 11676. Strain: bh10. Cell_line: 293. (1)
1BQNB:99-123,B:165-233; A:91-115,A:157-225; A:226-319; B:234-319; A:320-426; B:320-426TYR 188 LEU HIV-1 RT/HBY 097
(-)
Human immunodeficiency virus 1. Organism_taxid: 11676. Strain: hxb2 isolate. (6)
1TKTB:95-115,B:157-236; A:226-319; A:320-426; B:237-341; B:342-426; A:91-115,A:157-225CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GW426318
1TKXB:99-115,B:157-233; B:234-319; A:226-319; A:320-426; B:320-426; A:91-115,A:157-225CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GW490745
1TKZB:95-115,B:157-236; A:226-319; A:320-426; B:237-341; B:342-426; A:91-115,A:157-225CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GW429576
1TL1B:99-115,B:157-233; A:91-115,A:157-225; B:234-319; A:226-319; B:320-426; A:320-426CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GW451211
1TL3B:95-115,B:157-236; A:226-319; A:320-426; B:237-341; B:342-426; A:91-115,A:157-225CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GW450557
2HNZB:88-115,B:157-243; A:91-115,A:157-225; A:226-319; B:319-428; A:320-426; B:244-318CRYSTAL STRUCTURE OF E138K MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH PETT-2
(-)
Human immunodeficiency virus 1. Organism_taxid: 11676. Strain: hxb2 isolate. (3)
1FK9B:99-115,B:157-233; A:320-426; B:320-428; A:91-115,A:157-225; B:234-319; A:226-319CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH DMP-266(EFAVIRENZ)
1FKOB:95-115,B:157-233; A:226-319; A:320-426; B:320-426; A:91-115,A:157-225; B:234-319CRYSTAL STRUCTURE OF NNRTI RESISTANT K103N MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH DMP-266(EFAVIRENZ)
1FKPB:99-115,B:157-238; A:226-319; A:320-426; B:320-426; A:91-115,A:157-225; B:239-319CRYSTAL STRUCTURE OF NNRTI RESISTANT K103N MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH NEVIRAPINE
(-)
Human immunodeficiency virus 1. Organism_taxid: 11676. Strain: hxb2 isolate. Cell_line: 293. (8)
1KLMA:91-115,A:157-225; B:232-319; A:226-319; A:320-426; B:320-426; B:99-115,B:157-215HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH BHAP U-90152
1REVB:94-115,B:157-238; A:91-115,A:157-225; B:239-319; A:226-319; A:320-426; B:320-426HIV-1 REVERSE TRANSCRIPTASE
1RT1B:95-115,B:157-238; A:91-115,A:157-225; B:239-319; A:226-319; A:320-426; B:320-430CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH MKC-442
1RT2B:95-115,B:157-238; A:91-115,A:157-225; B:239-319; A:226-319; A:320-426; B:320-428CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH TNK-651
1RTHB:94-115,B:157-237; A:226-319; B:238-319; A:320-426; B:320-430; A:91-115,A:157-225HIGH RESOLUTION STRUCTURES OF HIV-1 RT FROM FOUR RT-INHIBITOR COMPLEXES
1RTIB:95-115,B:157-237; A:91-115,A:157-225; B:238-319; A:226-319; A:320-426; B:320-430HIGH RESOLUTION STRUCTURES OF HIV-1 RT FROM FOUR RT-INHIBITOR COMPLEXES
1RTJB:94-115,B:157-237; B:238-319; A:226-319; A:320-426; B:320-430; A:91-115,A:157-225MECHANISM OF INHIBITION OF HIV-1 REVERSE TRANSCRIPTASE BY NON-NUCLEOSIDE INHIBITORS
1VRTB:94-115,B:157-238; A:226-319; B:239-319; B:320-425; A:320-426; A:91-115,A:157-225HIGH RESOLUTION STRUCTURES OF HIV-1 RT FROM FOUR RT-INHIBITOR COMPLEXES
(-)
Human immunodeficiency virus 1. Organism_taxid: 11676. Strain: hxb2. (5)
1C0TA:91-115,A:157-225; B:236-319; A:226-319; A:320-426; B:320-426; B:99-123,B:160-235CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH BM+21.1326
1C0UB:99-115,B:157-233; B:234-319; A:226-319; A:320-426; B:320-426; A:91-115,A:157-225CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH BM+50.0934
1C1BB:99-115,B:157-233; A:226-319; A:320-426; B:320-426; A:92-115,A:157-225; B:234-319CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GCA-186
1C1CB:99-115,B:157-236; B:237-319; A:226-319; A:320-426; B:320-426; A:91-115,A:157-225CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH TNK-6123
1EP4A:91-115,A:157-225; A:226-319; B:320-424; A:320-426; B:99-115,B:157-215; B:232-319CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH S-1153
(-)
Human immunodeficiency virus 1. Organism_taxid: 11676. Strain: isolatebh10. (2)
2BE2B:99-123,B:165-233; A:91-115,A:157-225; A:226-319; B:234-319; B:320-425; A:320-426CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH R221239
2I5JB:99-123,B:165-233; A:320-426; B:320-426; A:91-115,A:157-225; A:226-319; B:234-319CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH DHBNH, AN RNASE H INHIBITOR
(-)
Human immunodeficiency virus 1. Organism_taxid: 11676. Strain: z2/cdc-z34 isolate. (1)
2JLEA:91-115,A:157-225; B:99-123,B:165-233; A:226-319; B:234-319; A:320-426; B:320-426NOVEL INDAZOLE NNRTIS CREATED USING MOLECULAR TEMPLATE HYBRIDIZATION BASED ON CRYSTALLOGRAPHIC OVERLAYS
(-)
Human immunodeficiency virus 1. Organism_taxid: 11676. Variant: hxb2 isolate. Cell_line: 293. (1)
1RT3B:99-115,B:157-233; B:234-319; A:226-319; B:320-425; A:320-426; A:91-115,A:157-225AZT DRUG RESISTANT HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH 1051U91
(-)
Human immunodeficiency virus 2. Organism_taxid: 11709. Strain: prod. (1)
1MU2A:91-115,A:157-225; B:91-115,B:157-233; A:226-319; B:234-319; A:320-425; B:320-425CRYSTAL STRUCTURE OF HIV-2 REVERSE TRANSCRIPTASE
(-)
Human immunodeficiency virus type 1 (clone 12). Organism_taxid: 11679.Strain: bh10. Cell_line: 293. (1)
1TVRB:95-115,B:157-238; A:91-115,A:157-225; A:226-319; B:239-316; A:320-426; B:317-426HIV-1 RT/9-CL TIBO
(-)
Human immunodeficiency virus type 1 bh10. Organism_taxid: 11678. (1)
1TV6A:91-115,A:157-225; B:239-316; A:319-428; B:317-427; B:93-115,B:157-238; A:226-318HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH CP-94,707
(-)
Human immunodeficiency virus type 1 bh10. Organism_taxid: 11678. (1)
1QE1B:99-115,B:157-233; A:91-115,A:157-225; A:226-319; B:234-319; A:320-426; B:320-426CRYSTAL STRUCTURE OF 3TC-RESISTANT M184I MUTANT OF HIV-1 REVERSE TRANSCRIPTASE
(-)
Human immunodeficiency virus type 1 bh10. Organism_taxid: 11678. Strain: bh10 isolate. (2)
2IAJB:95-115,B:157-235; A:91-115,A:157-225; A:226-319; B:236-319; B:320-425; A:320-426CRYSTAL STRUCTURE OF K103N/Y181C MUTANT HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH ATP
2IC3B:95-115,B:157-235; A:320-426; B:320-426; A:91-115,A:157-225; A:226-319; B:236-319CRYSTAL STRUCTURE OF K103N/Y181C MUTANT HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH NONNUCLEOSIDE INHIBITOR HBY 097
(-)
Human poliovirus 1 mahoney. Organism_taxid: 12081. Strain: mahoney. (4)
1RA6A:213-242,A:292-367POLIOVIRUS POLYMERASE FULL LENGTH APO STRUCTURE
1RA7A:213-242,A:292-367POLIOVIRUS POLYMERASE WITH GTP
1RAJA:223-240,A:294-367POLIOVIRUS POLYMERASE WITH A 68 RESIDUE N-TERMINAL TRUNCATION
2IJFA:213-242,A:292-367CRYSTAL STRUCTURE OF THE POLIOVIRUS RNA-DEPENDENT RNA POLYMERASE FIDELITY MUTANT 3DPOL G64S
(-)
Human poliovirus 1 mahoney. Organism_taxid: 12081. Strain: mahoney. Cell_line: bl21. (1)
1RDRA:223-240,A:292-367POLIOVIRUS 3D POLYMERASE
(-)
Human poliovirus 1. Organism_taxid: 12080. (1)
1TQLA:213-242,A:292-367POLIOVIRUS POLYMERASE G1A MUTANT
(-)
Human rhinovirus 14. Organism_taxid: 12131. (1)
1XR5A:213-242,A:291-366CRYSTAL STRUCTURE OF THE RNA-DEPENDENT RNA POLYMERASE 3D FROM HUMAN RHINOVIRUS SEROTYPE 14
(-)
Human rhinovirus 16. Organism_taxid: 31708. (2)
1TP7A:212-243,A:291-366; B:212-243,B:291-366; C:212-243,C:291-366; D:212-243,D:291-366CRYSTAL STRUCTURE OF THE RNA-DEPENDENT RNA POLYMERASE FROM HUMAN RHINOVIRUS 16
1XR7A:212-243,A:291-366; B:212-243,B:291-366CRYSTAL STRUCTURE OF RNA-DEPENDENT RNA POLYMERASE 3D FROM HUMAN RHINOVIRUS SEROTYPE 16
(-)
Human rhinovirus 1b. Organism_taxid: 12129. (1)
1XR6A:212-243,A:291-366CRYSTAL STRUCTURE OF RNA-DEPENDENT RNA POLYMERASE 3D FROM HUMAN RHINOVIRUS SEROTYPE 1B
(-)
Moloney murine leukemia virus (1)
3FSIA:25-50,A:125-158,A:188-273CRYSTAL STRUCTURE OF A TRYPANOCIDAL 4,4'-BIS(IMIDAZOLINYLAMINO) DIPHENYLAMINE BOUND TO DNA
(-)
Moloney murine leukemia virus. Organism_taxid: 11801. (3)
1MMLA:25-50,A:125-158,A:188-273MECHANISTIC IMPLICATIONS FROM THE STRUCTURE OF A CATALYTIC FRAGMENT OF MMLV REVERSE TRANSCRIPTASE
1NNDA:25-50,A:125-158,A:188-273ARGININE 116 IS ESSENTIAL FOR NUCLEIC ACID RECOGNITION BY THE FINGERS DOMAIN OF MOLONEY MURINE LEUKEMIA VIRUS REVERSE TRANSCRIPTASE
1RW3  [entry was replaced by entry 4MH8 without any CATH domain information]
(-)
Momlv (Moloney murine leukemia virus) (4)
2R2RA:25-50,A:125-158,A:188-273D(ATTAGTTATAACTAAT) COMPLEXED WITH MMLV RT CATALYTIC FRAGMENT
2R2SA:25-50,A:125-158,A:188-273CO(III)BLEOMYCINB2 BOUND TO D(ATTAGTTATAACTAAT) COMPLEXED WITH MMLV RT CATALYTIC FRAGMENT
2R2TA:25-50,A:125-158,A:188-273D(ATTTAGTTAACTAAAT) COMPLEXED WITH MMLV RT CATALYTIC FRAGMENT
2R2UA:25-50,A:125-158,A:188-273CO(III)BLEOMYCINB2 BITHIAZOLE/C-TERMINAL TAIL DOMAIN BOUND TO D(ATTTAGTTAACTAAAT) COMPLEXED WITH MMLV RT CATALYTIC FRAGMENT
(-)
Norovirus. Organism_taxid: 142786. (1)
2B43A:216-251,A:301-387; B:216-251,B:301-387; C:216-251,C:301-387; D:216-251,D:301-387CRYSTAL STRUCTURE OF THE NORWALK VIRUS RNA DEPENDENT RNA POLYMERASE FROM STRAIN HU/NLV/DRESDEN174/1997/GE
(-)
Norwalk virus. Organism_taxid: 11983. (3)
1SH0A:216-251,A:301-387; B:216-251,B:301-387CRYSTAL STRUCTURE OF NORWALK VIRUS POLYMERASE (TRICLINIC)
1SH2A:216-251,A:301-387CRYSTAL STRUCTURE OF NORWALK VIRUS POLYMERASE (METAL-FREE, CENTERED ORTHORHOMBIC)
1SH3A:216-251,A:301-387; B:216-251,B:301-387CRYSTAL STRUCTURE OF NORWALK VIRUS POLYMERASE (MGSO4 CRYSTAL FORM)
(-)
Rabbit hemorrhagic disease virus. Organism_taxid: 11976. (2)
1KHVA:220-251,A:306-403; B:220-251,B:306-403CRYSTAL STRUCTURE OF RABBIT HEMORRHAGIC DISEASE VIRUS RNA-DEPENDENT RNA POLYMERASE COMPLEXED WITH LU3+
1KHWA:220-251,A:306-403; B:220-251,B:306-403CRYSTAL STRUCTURE OF RABBIT HEMORRHAGIC DISEASE VIRUS RNA-DEPENDENT RNA POLYMERASE COMPLEXED WITH MN2+
(-)
Sulfolobus acidocaldarius. Organism_taxid: 2285. (3)
3BQ0A:2-10,A:78-166PRE-INSERTION BINARY COMPLEX OF DBH DNA POLYMERASE
3BQ1A:2-10,A:78-166INSERTION TERNARY COMPLEX OF DBH DNA POLYMERASE
3BQ2A:2-10,A:78-166POST-INSERTION BINARY COMPLEX OF DBH DNA POLYMERASE
(-)
Sulfolobus fataricus (Sulfolobus solfataricus) (3)
2BQ3A:2-10,A:78-166DNA ADDUCT BYPASS POLYMERIZATION BY SULFOLOBUS SOLFATARICUS DPO4. ANALYSIS AND CRYSTAL STRUCTURES OF MULTIPLE BASE-PAIR SUBSTITUTION AND FRAMESHIFT PRODUCTS WITH THE ADDUCT 1,N2-ETHENOGUANINE
2BQRA:2-10,A:78-166DNA ADDUCT BYPASS POLYMERIZATION BY SULFOLOBUS SOLFATARICUS DPO4. ANALYSIS AND CRYSTAL STRUCTURES OF MULTIPLE BASE-PAIR SUBSTITUTION AND FRAMESHIFT PRODUCTS WITH THE ADDUCT 1,N2-ETHENOGUANINE
2BQUA:2-10,A:78-166DNA ADDUCT BYPASS POLYMERIZATION BY SULFOLOBUS SOLFATARICUS DPO4. ANALYSIS AND CRYSTAL STRUCTURES OF MULTIPLE BASE-PAIR SUBSTITUTION AND FRAMESHIFT PRODUCTS WITH THE ADDUCT 1,N2-ETHENOGUANINE
(-)
Sulfolobus solfataricus (Sulfolobus solfataricus) (1)
2BR0A:2-10,A:78-166DNA ADDUCT BYPASS POLYMERIZATION BY SULFOLOBUS SOLFATARICUS DPO4. ANALYSIS AND CRYSTAL STRUCTURES OF MULTIPLE BASE-PAIR SUBSTITUTION AND FRAMESHIFT PRODUCTS WITH THE ADDUCT 1,N2-ETHENOGUANINE
(-)
Sulfolobus solfataricus p2. Organism_taxid: 273057. Strain: p2. (1)
2IBKA:2-10,A:78-166BYPASS OF MAJOR BENZOPYRENE-DG ADDUCT BY Y-FAMILY DNA POLYMERASE WITH UNIQUE STRUCTURAL GAP
(-)
Sulfolobus solfataricus. (1)
2R8GA:2-10,A:78-166SELECTIVITY OF NUCLEOSIDE TRIPHOSPHATE INCORPORATION OPPOSITE 1,N2-PROPANODEOXYGUANOSINE (PDG) BY THE SULFOLOBUS SOLFATARICUS DNA POLYMERASE DPO4 POLYMERASE
(-)
Sulfolobus solfataricus. Organism_taxid: 2287. (5)
1IM4A:-3-10,A:78-178CRYSTAL STRUCTURE OF A DINB HOMOLOG (DBH) LESION BYPASS DNA POLYMERASE CATALYTIC FRAGMENT FROM SULFOLOBUS SOLFATARICUS
1K1QA:2-10,A:78-166; B:2-10,B:78-166CRYSTAL STRUCTURE OF A DINB FAMILY ERROR PRONE DNA POLYMERASE FROM SULFOLOBUS SOLFATARICUS
1K1SA:2-10,A:78-166CRYSTAL STRUCTURE OF DINB FROM SULFOLOBUS SOLFATARICUS
2R8HA:2-10,A:78-166SELECTIVITY OF NUCLEOSIDE TRIPHOSPHATE INCORPORATION OPPOSITE 1,N2-PROPANODEOXYGUANOSINE (PDG) BY THE SULFOLOBUS SOLFATARICUS DNA POLYMERASE DPO4 POLYMERASE
2R8IA:2-10,A:78-166SELECTIVITY OF NUCLEOSIDE TRIPHOSPHATE INCORPORATION OPPOSITE 1,N2-PROPANODEOXYGUANOSINE (PDG) BY THE SULFOLOBUS SOLFATARICUS DNA POLYMERASE DPO4 POLYMERASE
(-)
Sulfolobus solfataricus. Organism_taxid: 2287. Strain: strain: p2. (1)
2J6SA:2-10,A:78-166TERNARY COMPLEX OF SULFOLOBUS SOLFATARICUS DPO4 DNA POLYMERASE, O6-METHYLGUANINE MODIFIED DNA, AND DATP.
(-)
Sulfolobus solfataricus. Organism_taxid: 273057. Strain: p2. (1)
2IA6A:2-10,A:78-166; B:2-10,B:78-166BYPASS OF MAJOR BENZOPYRENE-DG ADDUCT BY Y-FAMILY DNA POLYMERASE WITH UNIQUE STRUCTURAL GAP
(-)
Sulfolobus solfataricus. Organism_taxid: 273057. Strain: p2. (18)
2C22A:2-10,A:78-166EFFICIENT AND HIGH FIDELITY INCORPORATION OF DCTP OPPOSITE 7,8-DIHYDRO-8-OXODEOXYGUANOSINE BY SULFOLOBUS SOLFATARICUS DNA POLYMERASE DPO4
2C28A:2-10,A:78-166EFFICIENT AND HIGH FIDELITY INCORPORATION OF DCTP OPPOSITE 7,8-DIHYDRO-8-OXODEOXYGUANOSINE BY SULFOLOBUS SOLFATARICUS DNA POLYMERASE DPO4
2C2DA:2-10,A:78-166EFFICIENT AND HIGH FIDELITY INCORPORATION OF DCTP OPPOSITE 7,8-DIHYDRO-8-OXODEOXYGUANOSINE BY SULFOLOBUS SOLFATARICUS DNA POLYMERASE DPO4
2C2EA:2-10,A:78-166EFFICIENT AND HIGH FIDELITY INCORPORATION OF DCTP OPPOSITE 7,8-DIHYDRO-8-OXODEOXYGUANOSINE BY SULFOLOBUS SOLFATARICUS DNA POLYMERASE DPO4
2C2RA:2-10,A:78-166EFFICIENT AND HIGH FIDELITY INCORPORATION OF DCTP OPPOSITE 7,8-DIHYDRO-8-OXODEOXYGUANOSINE BY SULFOLOBUS SOLFATARICUS DNA POLYMERASE DPO4
2J6TA:2-10,A:78-166TERNARY COMPLEX OF SULFOLOBUS SOLFATARICUS DPO4 DNA POLYMERASE, O6-METHYLGUANINE MODIFIED DNA, AND DATP.
2J6UA:5-13,A:81-169TERNARY COMPLEX OF SULFOLOBUS SOLFATARICUS DPO4 DNA POLYMERASE, O6-METHYLGUANINE MODIFIED DNA, AND DGTP.
2JEFA:2-10,A:78-166THE MOLECULAR BASIS OF SELECTIVITY OF NUCLEOTIDE TRIPHOSPHATE INCORPORATION OPPOSITE O6-BENZYLGUANINE BY SULFOLOBUS SOLFATARICUS DNA POLYMERASE IV: STEADY-STATE AND PRE-STEADY-STATE AND X-RAY CRYSTALLOGRAPHY OF CORRECT AND INCORRECT PAIRING
2JEGA:2-10,A:78-166THE MOLECULAR BASIS OF SELECTIVITY OF NUCLEOSIDE TRIPHOSPHATE INCORPORATION OPPOSITE O6-BENZYLGUANINE BY SULFOLOBUS SOLFATARICUS DNA POLYMERASE IV: STEADY-STATE AND PRE-STEADY-STATE KINETICS AND X-RAY CRYSTALLOGRAPHY OF CORRECT AND INCORRECT PAIRING
2JEIA:2-10,A:78-166THE MOLECULAR BASIS OF SELECTIVITY OF NUCLEOSIDE TRIPHOSPHATE INCORPORATION OPPOSITE O6-BENZYLGUANINE BY SULFOLOBUS SOLFATARICUS DNA POLYMERASE IV: STEADY-STATE AND PRE-STEADY-STATE KINETICS AND X-RAY CRYSTALLOGRAPHY OF CORRECT AND INCORRECT PAIRING
2JEJA:2-10,A:78-166THE MOLECULAR BASIS OF SELECTIVITY OF NUCLEOSIDE TRIPHOSPHATE INCORPORATION OPPOSITE O6-BENZYLGUANINE BY SULFOLOBUS SOLFATARICUS DNA POLYMERASE IV: STEADY-STATE AND PRE-STEADY-STATE KINETICS AND X-RAY CRYSTALLOGRAPHY OF CORRECT AND INCORRECT PAIRING
2UVRA:2-10,A:78-166CRYSTAL STRUCTURES OF MUTANT DPO4 DNA POLYMERASES WITH 8-OXOG CONTAINING DNA TEMPLATE-PRIMER CONSTRUCTS
2UVUA:2-10,A:78-166CRYSTAL STRUCTURES OF MUTANT DPO4 DNA POLYMERASES WITH 8-OXOG CONTAINING DNA TEMPLATE-PRIMER CONSTRUCTS
2UVVA:2-10,A:78-166CRYSTAL STRUCTURES OF MUTANT DPO4 DNA POLYMERASES WITH 8-OXOG CONTAINING DNA TEMPLATE-PRIMER CONSTRUCTS
2UVWA:2-10,A:78-166CRYSTAL STRUCTURES OF MUTANT DPO4 DNA POLYMERASES WITH 8-OXOG CONTAINING DNA TEMPLATE-PRIMER CONSTRUCTS
2V9WA:2-10,A:78-166; B:2-10,B:78-166COMPLEX STRUCTURE OF SULFOLOBUS SOLFATARICUS DPO4 AND DNA DUPLEX CONTAINING A HYDROPHOBIC THYMINE ISOSTERE 2,4-DIFLUOROTOLUENE NUCLEOTIDE IN THE TEMPLATE STRAND
2VA2A:2-10,A:78-166; B:2-10,B:78-166COMPLEX STRUCTURE OF SULFOLOBUS SOLFATARICUS DPO4 AND DNA DUPLEX CONTAINING A HYDROPHOBIC THYMINE ISOSTERE 2,4-DIFLUOROTOLUENE NUCLEOTIDE IN THE TEMPLATE STRAND
2VA3A:2-10,A:78-166COMPLEX STRUCTURE OF SULFOLOBUS SOLFATARICUS DPO4 AND DNA DUPLEX CONTAINING A HYDROPHOBIC THYMINE ISOSTERE 2,4-DIFLUOROTOLUENE NUCLEOTIDE IN THE TEMPLATE STRAND
(-)
Sulfolobus solfataricus. Strain: p2. (1)
2RDJA:2-10,A:78-166; B:2-10,B:78-166SNAPSHOTS OF A Y-FAMILY DNA POLYMERASE IN REPLICATION: DPO4 IN APO AND BINARY/TERNARY COMPLEX FORMS